Hot Features
BCAL Diagnostics Limited, a screening and diagnostic company, engages in developing a novel blood screening test to improve the diagnosis and monitoring of breast cancer. It develops BREASTESTplus, a first-in-class blood test designed to be used alongside standard mammogram in breast cancer screenin... BCAL Diagnostics Limited, a screening and diagnostic company, engages in developing a novel blood screening test to improve the diagnosis and monitoring of breast cancer. It develops BREASTESTplus, a first-in-class blood test designed to be used alongside standard mammogram in breast cancer screening. The company also develops BREASTEST, BCAL Diagnostics, and BCAL Dx. The company was incorporated in 2010 and is headquartered in Sydney, Australia. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.005 | -6.32911392405 | 0.079 | 0.08 | 0.075 | 89899 | 0.07686409 | DE |
| 4 | -0.002 | -2.63157894737 | 0.076 | 0.096 | 0.071 | 134220 | 0.0773257 | DE |
| 12 | -0.041 | -35.652173913 | 0.115 | 0.115 | 0.071 | 168501 | 0.08921338 | DE |
| 26 | -0.031 | -29.5238095238 | 0.105 | 0.155 | 0.071 | 219136 | 0.10901733 | DE |
| 52 | -0.001 | -1.33333333333 | 0.075 | 0.155 | 0.052 | 278809 | 0.09025242 | DE |
| 156 | -0.026 | -26 | 0.1 | 0.21 | 0.052 | 330013 | 0.10575007 | DE |
| 260 | -0.176 | -70.4 | 0.25 | 0.25 | 0.051 | 310020 | 0.11514307 | DE |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.